Table 3

Clinical Outcomes: Summary of tumor response by RESIST criteria.

3A


N-patients

Number of Patients (%)


Complete Response

9 (64.3%)


Partial Response

1 (7.1%)


Stable Disease

1 (7.1%)


Progressed Disease

3 (21.4%)


N+ patients


Complete Response

1 (12.5%)


Progressed Disease

7 (87.5%)


3B


Clinical Stage

Complete Response

Partial Response

Stable Disease

Progressed Disease


rT0N1M0

1


rT0N0M1

1


rT2N0M0

3


rT3N0M0

3

1

1


rT3N1M0

2


rT3N2M0

1


rT4N0M0

3

2


rT4N1M0

2


rT4N2M0

2


(A) Tumor response for patients without lymph node metastases (N-) and for patients with lymph node metastases (N+). (B) Tumor response based on clinical stage.

Kawaguchi et al. Radiation Oncology 2010 5:51   doi:10.1186/1748-717X-5-51

Open Data